When did lorlatinib (lorlatinib) enter medical insurance?

Lorlatinib (Lolatinib) is a drug that targets ALK (amitogenic oncogene) and ROS1 (ROS1 gene rearrangement) targeted drugs for the treatment of specific types of advanced non-small cell lung cancer (NSCLC). As a new type of anti-tumor drug, lorlatinib (lorlatinib) brings new treatment hope to patients with advanced NSCLC by inhibiting the growth and spread of cancer cells and prolonging the survival time of patients.

在中国，劳拉替尼（洛拉替尼）已经在国内上市，并且于2023年被纳入了医保目录。 This means that eligible patients can purchase lorlatinib (lorlatinib) at domestic hospital pharmacies and can reduce the cost of the drug through medical insurance reimbursement. However, the price of lorlatinib is relatively high, about RMB 10,000 to 20,000. The specific medical insurance reimbursement price may vary depending on regional and hospital policies. Patients are advised to consult the local hospital pharmacy for detailed information.

In contrast, there are also original and generic drugs of lorlatinib (lorlatinib) in foreign markets, and there are certain differences in prices. For example, the price of original drugs in Turkey is relatively cheap, about more than 7,000 yuan, while the price of original drugs in Hong Kong is relatively high, about 30,000 yuan. In addition, some countries such as Laos and Bangladesh have also produced generic drugs of Lorlatinib. The price is about more than 1,000 yuan to several thousand yuan, and the ingredients are basically the same as the original drug.

The inclusion of lorlatinib in the medical insurance catalog means that domestic patients can enjoy the benefits of medical insurance reimbursement, thereby reducing the burden of drug costs.这对于晚期NSCLC患者来说是一个重要的利好消息，使得更多的患者能够获得这一创新药物的治疗。 At the same time, the price difference of lorlatinib also reminds patients that they need to choose purchasing channels carefully to ensure the quality and safety of the drug.

Overall, Lorlatinib (lorlatinib) 作为一种创新的靶向药物，在治疗晚期非小细胞肺癌方面显示出了显著的疗效。其纳入医保目录为患者提供了经济上的支持，使得更多的患者能够获得这一重要的治疗选择。然而，在选择购买时，患者需要根据自身情况和经济能力做出理性的选择，确保获得合适的治疗。